Frontlight ResearchEarly access
Trial site
Centro de especialidades médicas Vanguardia
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Epilepsy2 trials
- Lupus (SLE)2 trials
- Sjögren's disease2 trials
- Systemic sclerosis (scleroderma)2 trials
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Enrolling by invitation2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Amgen2 trials
- Biohaven Therapeutics Ltd.2 trials
- Viatris Innovation GmbH2 trials
- argenx1 trial
- Zura Bio Inc1 trial
Running trials
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Active, not recruiting
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Active, not recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Enrolling by invitation
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy1 recruiting
- Lupus (SLE)1 recruiting
- Sjögren's disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026